Table 8 Upregulated and downregulated expression patterns in AML.

From: In silico approaches unveil the mechanism of action of Eclipta prostrata against acute myeloid leukemia

Proteins

Regulation in

AML

Biomarker Validation

From TTD Database

Biomarker Validation

From Literature Mining

KIT

Upregulated

Diagnostic Biomarker (Acute Graft vs Host Disease)

90

FLT3

Upregulated

Prognostic Biomarker (Acute Myeloid Leukemia)

91

STAT3

Downregulated

Diagnostic Biomarker (Psoriatic arthritis)

92

PIK3CA

Upregulated

Not reported

Unavailable

PIK3CB

Upregulated

Not reported

Unavailable

PIK3CD

Upregulated

Not reported

Unavailable

PIK3R1

Upregulated

Not reported

Unavailable

AKT1

Upregulated

Not reported

Unavailable

MAPK1

Downregulated

Not reported

Unavailable

NFKB1/

RELA

Upregulated

Diagnostic Biomarker (Breast cancer)

93

PIM1

Downregulated

Not reported

Unavailable

PIM2

Downregulated

Not reported

Unavailable

MPO

Upregulated

Diagnostic and Prognostic Biomarkers

(Metabolic Disorders)

94